410 related articles for article (PubMed ID: 22443607)
21. Neutrophils cross the BBB primarily on transcellular pathways: an in vitro study.
von Wedel-Parlow M; Schrot S; Lemmen J; Treeratanapiboon L; Wegener J; Galla HJ
Brain Res; 2011 Jan; 1367():62-76. PubMed ID: 20875807
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo studies on the transport of PEGylated silica nanoparticles across the blood-brain barrier.
Liu D; Lin B; Shao W; Zhu Z; Ji T; Yang C
ACS Appl Mater Interfaces; 2014 Feb; 6(3):2131-6. PubMed ID: 24417514
[TBL] [Abstract][Full Text] [Related]
23. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
Wohlfart S; Khalansky AS; Gelperina S; Begley D; Kreuter J
J Control Release; 2011 Aug; 154(1):103-7. PubMed ID: 21616104
[TBL] [Abstract][Full Text] [Related]
25. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.
Rempe R; Cramer S; Hüwel S; Galla HJ
Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549
[TBL] [Abstract][Full Text] [Related]
26. Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis.
Ragnaill MN; Brown M; Ye D; Bramini M; Callanan S; Lynch I; Dawson KA
Eur J Pharm Biopharm; 2011 Apr; 77(3):360-7. PubMed ID: 21236340
[TBL] [Abstract][Full Text] [Related]
27. The MAP kinase pathway mediates transcytosis induced by TNF-alpha in an in vitro blood-brain barrier model.
Miller F; Fenart L; Landry V; Coisne C; Cecchelli R; Dehouck MP; Buée-Scherrer V
Eur J Neurosci; 2005 Aug; 22(4):835-44. PubMed ID: 16115207
[TBL] [Abstract][Full Text] [Related]
28. The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation.
Weiss CK; Kohnle MV; Landfester K; Hauk T; Fischer D; Schmitz-Wienke J; Mailänder V
ChemMedChem; 2008 Sep; 3(9):1395-403. PubMed ID: 18613205
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB).
Kreuter J
J Microencapsul; 2013; 30(1):49-54. PubMed ID: 22676632
[TBL] [Abstract][Full Text] [Related]
30. Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy.
Miao D; Jiang M; Liu Z; Gu G; Hu Q; Kang T; Song Q; Yao L; Li W; Gao X; Sun M; Chen J
Mol Pharm; 2014 Jan; 11(1):90-101. PubMed ID: 24295590
[TBL] [Abstract][Full Text] [Related]
31. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.
Pardridge WM; Triguero D; Yang J; Cancilla PA
J Pharmacol Exp Ther; 1990 May; 253(2):884-91. PubMed ID: 2338660
[TBL] [Abstract][Full Text] [Related]
32. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C
Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068
[TBL] [Abstract][Full Text] [Related]
33. Brain-targeting mechanisms of lactoferrin-modified DNA-loaded nanoparticles.
Huang R; Ke W; Han L; Liu Y; Shao K; Ye L; Lou J; Jiang C; Pei Y
J Cereb Blood Flow Metab; 2009 Dec; 29(12):1914-23. PubMed ID: 19654588
[TBL] [Abstract][Full Text] [Related]
34. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.
Liu Z; Jiang M; Kang T; Miao D; Gu G; Song Q; Yao L; Hu Q; Tu Y; Pang Z; Chen H; Jiang X; Gao X; Chen J
Biomaterials; 2013 May; 34(15):3870-81. PubMed ID: 23453061
[TBL] [Abstract][Full Text] [Related]
35. Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein.
Candela P; Gosselet F; Saint-Pol J; Sevin E; Boucau MC; Boulanger E; Cecchelli R; Fenart L
J Alzheimers Dis; 2010; 22(3):849-59. PubMed ID: 20858979
[TBL] [Abstract][Full Text] [Related]
36. A facile approach for the delivery of inorganic nanoparticles into the brain by passing through the blood-brain barrier (BBB).
Yim YS; Choi JS; Kim GT; Kim CH; Shin TH; Kim DG; Cheon J
Chem Commun (Camb); 2012 Jan; 48(1):61-3. PubMed ID: 22057099
[TBL] [Abstract][Full Text] [Related]
37. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
38. Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice.
Manich G; Cabezón I; del Valle J; Duran-Vilaregut J; Camins A; Pallàs M; Pelegrí C; Vilaplana J
Eur J Pharm Sci; 2013 Jul; 49(4):556-64. PubMed ID: 23748097
[TBL] [Abstract][Full Text] [Related]
39. Uptake and transcytosis of functionalized superparamagnetic iron oxide nanoparticles in an in vitro blood brain barrier model.
Ivask A; Pilkington EH; Blin T; Käkinen A; Vija H; Visnapuu M; Quinn JF; Whittaker MR; Qiao R; Davis TP; Ke PC; Voelcker NH
Biomater Sci; 2018 Jan; 6(2):314-323. PubMed ID: 29239410
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
